PD-L1 抗体 (AA 18-227)
Our Local Distributor
北京 101111
Quick Overview for PD-L1 抗体 (AA 18-227) (ABIN5027432)
抗原
See all PD-L1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 18-227
-
纯化方法
- Protein A Chromatography
-
免疫原
- A partial length recombinant PDL1 protein (amino acids 18-227) was used as the immunogen for this antibody.
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 2-4 μg/mL
-
限制
- 仅限研究用
-
-
-
浓度
- 0.5 mg/mL
-
缓冲液
- PBS containing 0.05 % BSA, PH 7.4
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
-
- PD-L1 (CD274 (PD-L1))
-
别名
- PD-L1 / CD274
-
背景
- Programmed death ligand 1/PD-L1 (also called B7-H1 and CD274) is a T cell inhibitory molecule that is expressed on antigen presenting cells (APC) leading to T cell anergy and/or apoptosis upon ligation to its receptor Programmed death-1 (PD-1, CD279) on T cells. PD-L1 is expressed on tumor cells of a subset of breast cancer patients. It could also induce EMT and enhance RCC cell cancer stemness through up-regulation of SREBP-1c. Blocking the immunosuppressive PD-1/PD-L1 pathway has antitumor activity in multiple cancer types, and PD-L1 expression on tumor cells and infiltrating myeloid cells correlates with the likelihood of response.
-
分子量
- 33 kDa
-
基因ID
- 29126
-
UniProt
- Q9NZQ7
-
途径
- Cancer Immune Checkpoints
抗原
-